Related Experiment Video
Updated: Sep 29, 2026

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
Published on: October 6, 2015
Reduced ADAMTS13 activity is associated with an ADAMTS13 SNP, fever and microparticles in a malaria-like model
Sirima Kraisin, Attakorn Palasuwan, Supaluk Popruk
1Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand. nantadao@gmail.com.
Background:
Severe falciparum malaria (SM) remains a major cause of death in tropical countries. The reduced activity of ADAMTS13, increasing levels of ultra-large von Willebrand factor (ULVWF) in SM patients, are assumed as factors that intensify disease severity. However, the reason why ADAMTS13 activity is reduced in SM remains unclear.
Objectives:
To investigate whether rs4962153, febrile temperature, and microparticles, contribute to reduced ADAMTS13 activity.
Methods:
Genotypic association of rs4962153 with ADAMTS13 antigen and activity was examined in 362 healthy Thai participants. The collagen binding assay was used to study the effects of febrile temperature and microparticles on ADAMTS13 activity.
Results:
ADAMTS13 antigen and activity were decreased in participants with AA genotype, compared to AG and GG (antigen: p-value = 0.014, and < 0.001; activity: p-value = 0.036, and < 0.002, respectively). There was significantly reduced ADAMTS13 antigen in AG compared to GG (p-value = 0.013), but not in ADAMTS13 activity (p-value = 0.082). The number of rs4962153 A alleles correlated with the reduced level of antigen and activity (p-value <0.001 and p-value = 0.001, respectively). MPs showed an inhibitory effect on ADAMTS13 activity (p-value = 0.025). Finally, ADAMTS13 activity was decreased in a temperature and time-dependent manner. The interaction between these two factors was also observed (p-value <0.001).
Conclusions:
These findings suggest that the A allele of rs4962153, MPs, and febrile temperature, contribute to reduce ADAMTS13 activity in plasma. These data are useful in malaria or other diseases with reduced ADAMTS13 activity.
Insights
Reduced ADAMTS13 activity in severe malaria is linked to the rs4962153 A allele, microparticles (MPs), and febrile temperatures. These factors contribute to decreased ADAMTS13 levels, impacting disease severity.
Area of Science:
- Hematology
- Genetics
- Infectious Diseases
Background:
- Severe falciparum malaria (SM) is a significant cause of mortality in tropical regions.
- Reduced ADAMTS13 activity and increased ultra-large von Willebrand factor (ULVWF) are implicated in SM severity.
- The underlying causes of decreased ADAMTS13 activity in SM are not fully understood.
Purpose of the Study:
- To investigate the contribution of the rs4962153 genetic variant, febrile temperature, and microparticles (MPs) to reduced ADAMTS13 activity.
- To explore the relationship between these factors and ADAMTS13 levels in the context of malaria.
Main Methods:
- Genotyping for rs4962153 and its association with ADAMTS13 antigen and activity in 362 healthy Thai participants.
- In vitro collagen binding assays to assess the impact of febrile temperatures and MPs on ADAMTS13 activity.
- Statistical analysis to determine correlations and interactions between genetic factors, environmental conditions, and ADAMTS13 function.
Main Results:
- The AA genotype of rs4962153 was associated with significantly lower ADAMTS13 antigen and activity compared to AG and GG genotypes.
- The presence of microparticles (MPs) demonstrated an inhibitory effect on ADAMTS13 activity.
- ADAMTS13 activity decreased in a temperature- and time-dependent manner, with a significant interaction between these factors.
Conclusions:
- The A allele of rs4962153, microparticles, and febrile temperatures are identified as contributors to reduced ADAMTS13 activity in plasma.
- These findings provide insights into the mechanisms underlying ADAMTS13 dysfunction in malaria.
- The data may be relevant for understanding and managing malaria and other diseases characterized by reduced ADAMTS13 activity.
Related Concept Videos
Malaria
Antiprotozoal Agents

